An intercross between APOL1 transgenic mice with a mouse model of HIVAN would provide an in vivo system to examine the podocyte function of APOL1-G0 and APOL1-G2 in the setting of a known human disease stressor. The gene discussed is APOL1; the disease is HIV-associated nephropathy.